Literature DB >> 29963454

Primary Gastric Lymphoma: Clinicopathological Profile.

Renuka Malipatel1, Mallikarjun Patil2, Patil Pritilata Rout1, Marjorie Correa1, Harshad Devarbhavi2.   

Abstract

INTRODUCTION: Gastrointestinal tract (GIT) is the most common site of involvement of extranodal non-Hodgkin's lymphoma (NHL). There is regional variation in anatomical distribution of extranodal NHL, stomach being the most common site followed by small intestine. Primary gastric lymphoma (PGL) predominantly involves the antrum and corpus of the stomach. It arises from mucosa-associated lymphoid tissue (MALT) and is of B-cell lineage and often associated with Helicobacter pylori infection. Primary gastric lymphoma often presents with nonspecific symptoms. The present study was undertaken to ascertain the clinicopathological characteristics of PGL at a tertiary care center in South India.
MATERIALS AND METHODS: It is a retrospective study from 2006 to 2016. Patient's data were obtained from institutional medical records. The histopathology slides were reviewed. The relevant immunohistochemistry (IHC) markers done were leukocyte common antigen (LCA), CD3, CD20, CD79a, CD10, Bcl-2, Bcl-6, CD5, Cyclin D1, CD138, and Ki-67. Correlating with the immunoprofile, further subtyping was done.
RESULTS: A total of 405 patients of NHL were seen during the study period, out of which 43 patients were PGL. There were 32 males and 11 females, with M:F of 2.9:1. The mean age at diagnosis was 58 years. Abdominal pain and new-onset dyspepsia were the commonly observed presenting symptoms. The common site of involvement was antrum (20). Diffuse large B-cell lymphoma (DLBCL) was the most common histological subtype. Helicobacter pylori infection was seen in 18 (41%) patients. Majority of the patients were in stages II and III.
CONCLUSION: In our study, the initial presentation of PGL was with nonspecific symptoms like abdominal pain and new-onset dyspepsia. High degree of suspicion of such symptoms and biopsy of all suspicious lesions is essential for early detection. Diffuse large B-cell lymphoma was the most common histological subtype seen in our study.How to cite this article: Malipatel R, Patil M, Rout P, Correa M, Devarbhavi H. Primary Gastric Lymphoma: Clinicopathological Profile. Euroasian J Hepato-Gastroenterol 2018;8(1):6-10.

Entities:  

Keywords:  Diffuse large B-cell lymphoma; Dyspepsia; Non-Hodgkin’s lymphoma; Primary gastric lymphoma.

Year:  2018        PMID: 29963454      PMCID: PMC6024034          DOI: 10.5005/jp-journals-10018-1250

Source DB:  PubMed          Journal:  Euroasian J Hepatogastroenterol        ISSN: 2231-5047


INTRODUCTION

Gastrointestinal tract is the most common site of involvement of extranodal NHL, stomach being the most common site of involvement , which accounts for less than 5% of primary gastric neoplasms.[1-4] The involvement of stomach by lymphomas can be primary or secondary as a part of systemic lymphomas. The primary GIT lymphomas are defined as those in which involvement of the alimentary tract predominates or those with symptoms of GIT involvement on presentation.[56] The diagnosis of PGL is often delayed due to nonspecific initial symptoms like vague abdominal pain and new-onset dyspepsia.[7] Primary gastric lymphoma predominantly involves the antrum and corpus of the stomach, arise from MALT, and are of B-cell lineage.[89] The different subtypes are DLBCL, extranodal marginal lymphomas of MALTs, Mantle cell lymphoma, follicular lymphoma, and very rarely T-cell lymphomas.[10-12] The present study was undertaken to ascertain the clinicopathological characteristics of PGL at a tertiary care center.

MATERIALS AND METHODS

The present study was retrospectively carried out in the Departments of Pathology and Gastroenterology, St. John’s Medical College, Bengaluru, Karnataka, India, from 2006 to 2016 (10 years). Patients’ data were collected from the institutional medical records. Patients presenting with GI symptoms or predominant tumor(s) in the GI tract were included as PGL based on Lewin et al definition.[5] All patients underwent upper GI endoscopy (esophagogastroduodenoscopy) and gastric biopsy except one where laparotomy was done. The biopsies were processed in 10% formalin. Hematoxylin and eosin staining (H&E) was done on paraffin-embedded sections. The presence of H. pylori in the adjacent mucosa was noted. Immunohistochemistry was carried out manually on poly L-lysine-coated slides and controls run were satisfactory. Heat-induced antigen retrieval was done by pressure cooking the sections kept in Tris-ethylenediaminetetraacetic acid buffer. Avidin-Biotin peroxidase technique was used. The relevant IHC markers done were LCA, CD3, CD20, CD79a, CD10, Bcl-2, Bcl-6, CD5, Cyclin D1, CD138, and Ki-67. Correlating with the immunoprofile, further subtyping was done. In all patients, physical examination, indirect laryngoscopy, complete blood count, liver function tests, lactate dehydrogenase, bone marrow examination, Chest X-ray, and computed tomography scan of the chest, abdomen, and pelvis were done for staging. Patients with systemic lymphomas involving the stomach were excluded from the study. Table 1: Various symptoms at presentation Table 2: Primary gastric lymphoma staging at presentation Endoscopic images showing thickened gastric folds (A), nodular lesions (B), and ulcerated lesions; (C) ulcerated lesion in the fundus of stomach; and (D) ulcerated lesion in the antrum

RESULTS

During the study period between 2006 and 2016, total 405 patients of NHL were seen, out of which 43 patients were PGL, constituting 10.6% of all NHL. There were 32 males and 11 females, with M:F of 2.9:1. The mean age at diagnosis was 58 years. Abdominal pain and new-onset dyspepsia were the common presenting symptoms as shown in Table 1. The staging at the time of diagnosis was as shown in Table 2. The various sites of involvement were antrum (20), body (12), diffuse lesions (9), and fundus (2). The endoscopic appearances of PGL were as shown in Figure 1, ulcerated lesions (10), polypoidal lesions (19), thickened gastric folds (12), and erosions (2). The frequencies of various histological subtypes of PGL are listed in Table 3 and Figures 2 to 4. Helicobacter pylori infection was seen in 18 (41%) patients.

Table 1: Various symptoms at presentation

Symptom    No. of cases (n = 43)    
Abdominal pain    15 (34.8%)    
New-onset dyspepsia    12 (27.9%)    
Gastric outlet obstruction    7 (16.27%)    
GI bleed    6 (13.95%)    
Dysphagia    2 (4.6%)    
Obstructive jaundice    1 (2.3%)    

Table 2: Primary gastric lymphoma staging at presentation

Stage    No. of cases (n = 43)    
IE    1 (2.3%)    
I IE    26 (60.5%)    
III    9 (20.9%)    
IV    7 (16.27%)    
Figs 1A to D:

Endoscopic images showing thickened gastric folds (A), nodular lesions (B), and ulcerated lesions; (C) ulcerated lesion in the fundus of stomach; and (D) ulcerated lesion in the antrum

Table 3: Primary gastric lymphoma histological subtypes

Diagnosis    No. of cases (n = 43)    
Diffuse large B-cell lymphoma    27 (62.8%)    
Low-grade marginal zone lymphoma of    15 (34.8%)    
MALT type        
Follicular lymphoma    1 (2.3%)    
Figs 2A to F:

A case of DLBCL stomach showing sheets of monomorphic lymphoid cells (H&E stain, 400*) which express LCA, CD20, Bcl-2, Bcl-6. The i-67 proliferative index is 90%

Fig. 4:

Stomach biopsy showing monomorphic lymphoid cell infiltrate and lymphoepithelial lesions

Table 3: Primary gastric lymphoma histological subtypes

DISCUSSION

Gastrointestinal tract is the most common site of involvement for extranodal lymphoma, with stomach being the commonest. In our study, PGL constituted 10.6% of all NHL. The normal gastric mucosa is devoid of lymphatic tissue.[1] The lymphoid tissue appears in the stomach in response to chronic inflammation induced by H. pylori infection. Most of the gastric lymphomas are thought to arise from the B-cell lineage of MALT. The presence of immunological evidence of H. pylori infection among patients with gastric lymphoma than matched controls[23] and response to H. pylori eradication therapy[45] proves the role of H. pylori infection in the pathogenesis of gastric lymphoma. In our study, H. pylori infection was seen in 41% of patients as compared with other studies which reported 75% by Shukla et al,[6] 44% by Arora et al[7] and 85% by Delchier et al.[8] Low prevalence of H. pylori in our study could be due to the diagnosis of H. pylori infection made only on histology and serological test was not used. Diffuse large B-cell lymphoma was the commonest histologic type seen in our study, which was similar to other studies from India and other parts of the world.[7910] Follicular lymphoma of the stomach is rare. In our study, there was one case of follicular lymphoma that presented with obstructive symptoms and required laparotomy. As observed in other studies, PGL in our study was seen in elderly people, predominantly in males.[71112] Like in other studies the common presenting complaints were abdominal pain, new-onset dyspepsia, features of gastric outlet obstruction, anemia due to GI blood loss, jaundice, and dysphagia.[13-15] None of the patients had B constitutional symptoms due to lymphoma. At the time of diagnosis majority of the patients were in stages II and III. Such late detection could be due to initial nonspecific symptoms. A case of DLBCL stomach showing sheets of monomorphic lymphoid cells (H&E stain, 400*) which express LCA, CD20, Bcl-2, Bcl-6. The i-67 proliferative index is 90% Resection specimen of stomach showing closely packed follicles of varying sizes (100*). These follicles are composed of centrocytes and centroblasts (higher magnification, 400*) Stomach biopsy showing monomorphic lymphoid cell infiltrate and lymphoepithelial lesions

CONCLUSION

Primary gastric lymphomas present with initial nonspecific symptoms leading to delay in diagnosis. Hence, it is important to detect them at the earliest. Further studies on genetic and molecular profiling are necessary for understanding the pathogenetic mechanisms involved and for therapeutic and prognostic implications in different subtypes of PGL.
  15 in total

Review 1.  The gastric marginal zone B-cell lymphoma of MALT type.

Authors:  E Zucca; F Bertoni; E Roggero; F Cavalli
Journal:  Blood       Date:  2000-07-15       Impact factor: 22.113

2.  Helicobacter pylori gastritis and gastric MALT-lymphoma.

Authors:  M Stolte
Journal:  Lancet       Date:  1992-03-21       Impact factor: 79.321

3.  Role of surgery in multimodality therapy for gastrointestinal lymphoma.

Authors:  V L Rackner; R C Thirlby; J A Ryan
Journal:  Am J Surg       Date:  1991-05       Impact factor: 2.565

4.  Primary Gastrointestinal Non-Hodgkin's Lymphoma: A Retrospective Study with Emphasis on Prognostic Factors and Treatment Outcome.

Authors:  Hanan Shawky; Hesham Tawfik
Journal:  J Egypt Natl Canc Inst       Date:  2008-12

5.  Non-Hodgkin's lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group.

Authors:  F d'Amore; H Brincker; K Grønbaek; K Thorling; M Pedersen; M K Jensen; E Andersen; N T Pedersen; L S Mortensen
Journal:  J Clin Oncol       Date:  1994-08       Impact factor: 44.544

6.  Gastric lymphoma in Grampian Region: presentation, treatment and outcome.

Authors:  A G Sutherland; M Kennedy; D N Anderson; K G Park; R A Keenan; A I Davidson
Journal:  J R Coll Surg Edinb       Date:  1996-06

7.  Primary gastrointestinal non Hodgkin's lymphoma chemotherapy alone an effective treatment modality: experience from a single centre in India.

Authors:  Vinod Raina; Atul Sharma; Amish Vora; N K Shukla; S V S Deo; R Dawar
Journal:  Indian J Cancer       Date:  2006 Jan-Mar       Impact factor: 1.224

8.  Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type.

Authors:  J C Delchier; D Lamarque; M Levy; E M Tkoub; C Copie-Bergman; L Deforges; M T Chaumette; C Haioun
Journal:  Am J Gastroenterol       Date:  2001-08       Impact factor: 10.864

9.  Primary gastric lymphomas. A clinicopathologic study of 58 cases with long-term follow-up and literature review.

Authors:  J J Brooks; H T Enterline
Journal:  Cancer       Date:  1983-02-15       Impact factor: 6.860

10.  Clinicopathological profile of gastrointestinal lymphomas in Kashmir.

Authors:  Mehnaaz Sultan Khuroo; Summyia Farooq Khwaja; Ajaz Rather; Zhahid Hassan; Ruby Reshi; Naira Sultan Khuroo
Journal:  Indian J Med Paediatr Oncol       Date:  2016 Oct-Dec
View more
  4 in total

1.  A Retrospective Analysis of Primary Gastrointestinal Non-Hodgkin Lymphomas: Clinical Features, Prognostic Factors and Treatment Outcomes.

Authors:  Chen Tian; Yueyang Li; Zehui Chen
Journal:  Onco Targets Ther       Date:  2020-06-10       Impact factor: 4.147

2.  PD-L1 and miR-34a are Prognostic Factors for Primary Gastric Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP.

Authors:  Jinfeng Wang; Song Shang; Junjun Li; Hongyu Deng; Linda Ouyang; Hailong Xie; Haizhen Zhu; Yajun Li; Chaohui Zuo
Journal:  Cancer Manag Res       Date:  2020-06-25       Impact factor: 3.989

3.  Primary Intestinal Lymphoma: Clinicopathological Characteristics of 55 Patients.

Authors:  Renuka Malipatel; Mallikarjun Patil; Pritilata Rout; Marjorie Correa; Harshad Devarbhavi
Journal:  Euroasian J Hepatogastroenterol       Date:  2021 Jul-Dec

4.  Expression of PD-L1 and YWHAZ in Patients with Diffuse Large B Cell Lymphoma: A Possible Association with the Prognosis of Lymphoma.

Authors:  Shufang Yan; Qinyu Shang; Zhaopu Fan; Yuping Yang; Yanping Liu; Hongliang Gao; Ken Chen; Fei Liang; Xinxia Li; Qian Zhang; Huifang Yan
Journal:  J Immunol Res       Date:  2022-09-28       Impact factor: 4.493

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.